Companies: 10,795·Total market cap: $144.5T
Boundless Bio, Inc.

Boundless Bio, Inc.

BOLDNASDAQHealthcare● Active
$1.43
+$0.01(+0.70%)
Market Cap$32123679
P/E Ratio
52W High$1.68
52W Low$0.961
Overview

Boundless Bio, Inc.(BOLD)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BOLD · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-2.50bold eps ttm · bold earnings per shareEarnings history
PE Ratio (TTM)bold pe ratio ttm · bold price to earningsPE Ratio deep dive
Revenue (TTM)0.00bold revenue ttm · bold annual revenueFull revenue history
Dividend Yield不分红does bold pay dividends · bold dividend yieldDividend history
Shares Outstanding22.4Mbold shares outstanding · bold floatShares outstanding history
Next EarningsAug 4, 2026Est.bold earnings date · bold next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
boundless bio, inc. revenue · bold revenue 2025
FY 2025Net Income-$58.2M▲ +10.96% YoY
202320242025
boundless bio, inc. net income · bold profit 2025
FY 2025EPS$-2.60▲ +32.47% YoY
202320242025
bold eps · boundless bio, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$56.0MEPS: $-2.50View income statement →

分析师评级与目标价

完整预测
SellBuy
Hold20 位分析师is bold a buy · bold analyst rating
Strong Buy
0
Buy
6
Hold
13
Sell
1
Strong Sell
0
12-Month Price Target
$Low
$1.43Current
$Avg Target
$High
bold price target · bold 12 month forecast

合计: 20 · 买入占比: 30.0%

股票表现

完整历史
1D+0.70%
1W-0.69%
1M-0.69%
3M+26.55%
YTD+19.17%
1Y+30.00%
5Y-89.96%

关于 Boundless Bio, Inc.

CEOZachary Hornby
IPO DateJul 20, 2016
Employees64
CountryUS

Boundless Bio, Inc. a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Th…

what is boundless bio, inc. · bold stock overview · boundless bio, inc. company profile · who is boundless bio, inc. ceo · bold NASDAQ · boundless bio, inc. headquarters · boundless bio, inc. business segments

关于股票概览与关键数据

Boundless Bio, Inc.(BOLD)是 Biotechnology 行业的 Healthcare 类公司,于 Jul 20, 2016 在 NASDAQ 上市。截至最近交易日,BOLD 股价为 $1.43,市值约为 $32.1M。过去12个月累计回报 +30.00%,年初至今回报 +19.17%。

根据 20 位华尔街分析师,Boundless Bio, Inc. 股票共识评级为Hold,12个月平均目标价为 $—。2025 财年 Boundless Bio, Inc. 营收 —,净利润 -$58.2M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Boundless Bio, Inc.(BOLD)股价为 $1.43,在 NASDAQ 上市,52周区间为 $0.96 – $1.68。

BOLD 最新股价BOLD quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议